177 related articles for article (PubMed ID: 30333570)
21. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses.
Spaan M; Kreefft K; de Graav GN; Brouwer WP; de Knegt RJ; ten Kate FJ; Baan CC; Vanwolleghem T; Janssen HL; Boonstra A
J Hepatol; 2015 Feb; 62(2):303-10. PubMed ID: 25281860
[TBL] [Abstract][Full Text] [Related]
22. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
[TBL] [Abstract][Full Text] [Related]
23. Increased CD40L+PD-1+ follicular helper T cells (Tfh) as a biomarker for predicting calcineurin inhibitor sensitivity against Tfh-mediated B-cell activation/antibody production after kidney transplantation.
Iwasaki K; Kitahata N; Hiramitsu T; Yamamoto T; Noda T; Okada M; Narumi S; Watarai Y; Miwa Y; Uchida K; Matsuoka Y; Horimi K; Kobayashi T
Int Immunol; 2018 Jul; 30(8):345-355. PubMed ID: 29878122
[TBL] [Abstract][Full Text] [Related]
24. T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran.
Assar S; Arababadi MK; Mohit M; Ahmadabadi BN; Pumpens P; Khorramdelazad H; Hajghani M; Assar S; Araste M; Nekhei Z; Sendi H; Kennedy D
Clin Lab; 2012; 58(1-2):53-60. PubMed ID: 22372345
[TBL] [Abstract][Full Text] [Related]
25. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
Muselmani W; Habbal W; Monem F
Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
[TBL] [Abstract][Full Text] [Related]
26. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
Barnaba V; Valesini G; Levrero M; Zaccari C; Van Dyke A; Falco M; Musca A; Balsano F
Clin Exp Immunol; 1985 May; 60(2):259-66. PubMed ID: 3874020
[TBL] [Abstract][Full Text] [Related]
27. Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells.
Wang R; Xie R; Song Z
Exp Cell Res; 2018 Apr; 365(2):171-176. PubMed ID: 29501568
[TBL] [Abstract][Full Text] [Related]
28. Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes.
Dement-Brown J; Newton CS; Ise T; Damdinsuren B; Nagata S; Tolnay M
J Leukoc Biol; 2012 Jan; 91(1):59-67. PubMed ID: 22028333
[TBL] [Abstract][Full Text] [Related]
29. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
[TBL] [Abstract][Full Text] [Related]
30. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.
Zhang Z; Jin B; Zhang JY; Xu B; Wang H; Shi M; Wherry EJ; Lau GK; Wang FS
J Hepatol; 2009 Jun; 50(6):1163-73. PubMed ID: 19395117
[TBL] [Abstract][Full Text] [Related]
31. Pregnancy favors the expansion of circulating functional follicular helper T Cells.
Monteiro C; Kasahara TM; Castro JR; Sacramento PM; Hygino J; Centurião N; Cassano T; Lopes LMF; Leite S; Silva VG; Gupta S; Bento CAM
J Reprod Immunol; 2017 Jun; 121():1-10. PubMed ID: 28482188
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
[TBL] [Abstract][Full Text] [Related]
33. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
35. CD21 and FCRL5 form a receptor complex with robust B-cell activating capacity.
Franco A; Kraus Z; Li H; Seibert N; Dement-Brown J; Tolnay M
Int Immunol; 2018 Nov; 30(12):569-578. PubMed ID: 30107486
[TBL] [Abstract][Full Text] [Related]
36. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.
Marusawa H; Uemoto S; Hijikata M; Ueda Y; Tanaka K; Shimotohno K; Chiba T
Hepatology; 2000 Feb; 31(2):488-95. PubMed ID: 10655275
[TBL] [Abstract][Full Text] [Related]
37. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
38. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
Yang HC; Tsou HH; Pei SN; Chang CS; Chen JH; Yao M; Lin SJ; Lin J; Yuan Q; Xia N; Liu TW; Chen PJ; Cheng AL; Hsu C;
J Hepatol; 2018 Aug; 69(2):286-292. PubMed ID: 29551710
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.
Rinker F; Zimmer CL; Höner Zu Siederdissen C; Manns MP; Kraft ARM; Wedemeyer H; Björkström NK; Cornberg M
J Hepatol; 2018 Sep; 69(3):584-593. PubMed ID: 29758333
[TBL] [Abstract][Full Text] [Related]
40. Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.
Wilson TJ; Fuchs A; Colonna M
J Immunol; 2012 May; 188(10):4741-5. PubMed ID: 22491254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
